Literature DB >> 19142660

Ethical principles and legal requirements for pediatric research in the EU: an analysis of the European normative and legal framework surrounding pediatric clinical trials.

Wim Pinxten1, Kris Dierickx, Herman Nys.   

Abstract

The involvement of minors in clinical research is inevitable to catch up with the lack of drugs labeled for pediatric use. To encourage the responsible conduct of pediatric clinical trials in the EU, an extensive legal framework has been developed over the past decade in which the practical, ethical, legal, social, and commercial issues in pediatric research are addressed. In this article, the European legal framework surrounding pediatric clinical trials is analyzed from the perspective of the major ethical concerns in pediatric research. The four principles of biomedical ethics will be used as a conceptual framework (1) to map the ethical issues addressed in the European legal framework, (2) to study how these issues are commonly handled in competent adults, (3) to detect workability problems of these paradigmatic approaches in the specific setting of pediatric research, and (4) to illustrate the strong urge to differentiate, specify, or adjust these paradigmatic approaches to guarantee their successful operation in pediatric research. In addition, a concise comparative analysis of the European regulation will be made. To conclude our analysis, we integrate our findings in the existing ethical discussions on issues specific to pediatric clinical research.

Mesh:

Year:  2009        PMID: 19142660     DOI: 10.1007/s00431-008-0915-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  23 in total

1.  Children's consent to research participation: social context and personal experience invalidate fixed cutoff rules.

Authors:  Richard Ashcroft; Trudy Goodenough; Emma Williamson; Julie Kent
Journal:  Am J Bioeth       Date:  2003       Impact factor: 11.229

Review 2.  The march toward rational therapeutics in children.

Authors:  Richard L Gorman
Journal:  Pediatr Infect Dis J       Date:  2003-12       Impact factor: 2.129

3.  Therapeutic misconception and the appreciation of risks in clinical trials.

Authors:  Charles W Lidz; Paul S Appelbaum; Thomas Grisso; Michelle Renaud
Journal:  Soc Sci Med       Date:  2004-05       Impact factor: 4.634

4.  Improving pediatric dosing through pediatric initiatives: what we have learned.

Authors:  William Rodriguez; Arzu Selen; Debbie Avant; Chandra Chaurasia; Terrie Crescenzi; Gerlie Gieser; Jennifer Di Giacinto; Shiew-Mei Huang; Peter Lee; Lisa Mathis; Dianne Murphy; Shirley Murphy; Rosemary Roberts; Hari Cheryl Sachs; Sandra Suarez; Veneeta Tandon; Ramana S Uppoor
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

5.  Economic return of clinical trials performed under the pediatric exclusivity program.

Authors:  Jennifer S Li; Eric L Eisenstein; Henry G Grabowski; Elizabeth D Reid; Barry Mangum; Kevin A Schulman; John V Goldsmith; M Dianne Murphy; Robert M Califf; Daniel K Benjamin
Journal:  JAMA       Date:  2007-02-07       Impact factor: 56.272

6.  Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children.

Authors:  S Conroy; C Newman; S Gudka
Journal:  Ann Oncol       Date:  2003-01       Impact factor: 32.976

7.  Patient recruitment--European perspective.

Authors:  K Hoppu
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

8.  Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine (adopted by the Committee of Ministers on 19 November 1996). Council of Europe Convention of Biomedicine.

Authors: 
Journal:  Hum Reprod       Date:  1997-09       Impact factor: 6.918

Review 9.  Developing paediatric medicines: identifying the needs and recognizing the challenges.

Authors:  Terry B Ernest; David P Elder; Luigi G Martini; Matthew Roberts; James L Ford
Journal:  J Pharm Pharmacol       Date:  2007-08       Impact factor: 3.765

10.  Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception.

Authors:  I S Durand-Zaleski; C Alberti; P Durieux; X Duval; S Gottot; Ph Ravaud; S Gainotti; C Vincent-Genod; D Moreau; P Amiel
Journal:  J Med Ethics       Date:  2008-09       Impact factor: 2.903

View more
  5 in total

Review 1.  Ethical aspects of clinical research with minors.

Authors:  Wendy Bos; Krista Tromp; Dick Tibboel; Wim Pinxten
Journal:  Eur J Pediatr       Date:  2012-10-17       Impact factor: 3.183

2.  Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology.

Authors:  Karel Allegaert
Journal:  World J Clin Pediatr       Date:  2012-08-08

3.  Developing a policy for paediatric biobanks: principles for good practice.

Authors:  Kristien Hens; Carla E Van El; Pascal Borry; Anne Cambon-Thomsen; Martina C Cornel; Francesca Forzano; Anneke Lucassen; Christine Patch; Lisbeth Tranebjaerg; Eric Vermeulen; Elena Salvaterra; Aad Tibben; Kris Dierickx
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

4.  Consent to research participation: understanding and motivation among German pupils.

Authors:  Jana Reetz; Gesine Richter; Christoph Borzikowsky; Christine Glinicke; Stephanie Darabaneanu; Alena Buyx
Journal:  BMC Med Ethics       Date:  2021-07-16       Impact factor: 2.652

5.  Ethical challenges in consent procedures involving pediatric cancer patients in Saudi Arabia: An exploratory survey.

Authors:  Ghiath Alahmad; Muneera AlSaqabi; Hala Alkamli; Mona Aleidan
Journal:  Dev World Bioeth       Date:  2021-02-19       Impact factor: 2.427

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.